Hepatocyte-targeting vehicle for delivery of glargine...

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S078080, C424S200100

Reexamination Certificate

active

07871641

ABSTRACT:
The instant invention is drawn to a hepatocyte targeted composition comprising a mixture of free glargine insulin and glargine insulin associated with a water insoluble target molecule complex, wherein the complex comprises multiple linked individual units and a supra-molecular lipid construct matrix. Glargine insulin is present within the complex in at least one form wherein the glargine insulin has a positive charge which interacts with a negative charge on the complex. The invention also includes methods for the manufacture of the composition and methods of managing blood glucose levels in individuals with Type I and Type II diabetes.

REFERENCES:
patent: 4603044 (1986-07-01), Geho et al.
patent: 4963526 (1990-10-01), Ecanow
patent: WO 88/00474 (1988-01-01), None
patent: WO 99/59545 (A1) (1999-11-01), None
Heinemann et al., Diabetes Care 23: 644-649, 2000.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hepatocyte-targeting vehicle for delivery of glargine... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hepatocyte-targeting vehicle for delivery of glargine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatocyte-targeting vehicle for delivery of glargine... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2626283

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.